Prostate Cancer
New AI Tool Predicts Prostate Cancer Treatment Success
A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.
Read More
Transforming Prostate Cancer Care Through Personalized Medicine
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
Listen
FDA OKs TLX007-CDx in Prostate Cancer Treatment
TLX007-CDx is now an FDA-approved PSMA PET imaging agent in prostate cancer.
Dizman’s Global Pursuit to Cancer Research and Understanding
In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.
Analyzing AE Data to Guide Selection of Androgen Receptor Inhibitors in mHSPC
Phase 3 Trial of the ArteraAI Prostate Test Begins Enrollment
The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test.
